Citas bibligráficas
Colqui, H., Guevara, R. (2023). Plan estratégico para la alianza Pillsens-CVS y la introducción del producto MoradOx en el periodo 2022-2026 [Universidad del Pacífico]. https://hdl.handle.net/11354/4128
Colqui, H., Guevara, R. Plan estratégico para la alianza Pillsens-CVS y la introducción del producto MoradOx en el periodo 2022-2026 []. PE: Universidad del Pacífico; 2023. https://hdl.handle.net/11354/4128
@mastersthesis{sunedu/3488654,
title = "Plan estratégico para la alianza Pillsens-CVS y la introducción del producto MoradOx en el periodo 2022-2026",
author = "Guevara Amoretti, Richard Bryan",
publisher = "Universidad del Pacífico",
year = "2023"
}
This paper presents a strategic plan for Pillsens, a leading pharmaceutical company, to address market challenges and improve its profitability over the next five years. Despite achieving a 15% market share in the over-the-counter medication market, Pillsens' profitability has been affected by changing demand and intense competition. On the other hand, the market study reveals a clear opportunity in the pharmaceutical industry to develop natural products that strengthen the immune system and prevent disease. This opportunity arises in response to growing consumer demand for healthy choices and consumer appreciation of sustainable and caring brands.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons